Teza Capital Management LLC Bluebird Bio, Inc. Transaction History

Teza Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$34.44 - $43.75 $455,227 - $578,287	-13,218 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$27.12 - $45.97 $358,472 - $607,631	13,218 New	13,218 $807,000
Q1 2020 May 11, 2020	SELL	$26.16 - $63.5 $69,167 - $167,894	-2,644 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$46.96 - $61.67 $130,032 - $170,764	-2,769 Reduced 51.15%	2,644 $232,000
Q3 2019 Nov 12, 2019	BUY	$59.47 - $93.1 $321,911 - $503,950	5,413 New	5,413 $497,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.